Samantha South

Rage Biotech Pty Ltd. is an Australian biotech company founded in 2020 that is developing novel therapeutics for patients with difficult-to-treat inflammatory diseases. The company is based in Southbank, Australia. Rage Biotech is focused on targeting the receptor for advanced glycation end-products (RAGE), which is an important therapeutic target in a wide range of inflammatory diseases. The company is harnessing cutting-edge RNA-targeting and therapeutic peptide technologies to bring an effective RAGE inhibitor to the clinic. The aim of the company is to improve the lives of people with chronic inflammatory conditions around the world. The company has a team of experienced management, founders, and advisors who are working towards achieving this goal. Recently, Rage Biotech participated in the American Thoracic Society meeting 'Respiratory Innovation Summit' in DC, where it was selected as a featured showcase company.

MiReven Pty Ltd. operates as an Australian biopharmaceutical company. The private company is based in Nedlands, Australia.

OncoRes Medical Pty Ltd. develops an imaging medical device which provides micro-scale images of tissue stiffness and elasticity information to surgeons. The company is headquartered in Nedlands, Australia.